Texas Oncology-Garland

Public research footprint of Texas Oncology-Garland, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Completed

Most-studied conditions

Stage IIA Breast Cancer AJCC v6 and v7 · Stage IIB Breast Cancer AJCC v6 and v7 · Stage IB Breast Cancer AJCC v7 · Stage IIIA Breast Cancer AJCC v7

Recently updated registry entries

NCT02488967 — Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without… (Active Not Recruiting)
NCT01275677 — Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive… (Completed)
NCT02627963 — A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory… (Completed)

Work at Texas Oncology-Garland?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.